Avanafil Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
- 99S4164452
- 91 Pages
- January 2020
- Medical Devices
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Avanafil market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Avanafil market segmented into
50 mg Avanafil
100 mg Avanafil
200 mg Avanafil
Based on the end-use, the global Avanafil market classified into
Hospital
Pharmacy
Online
Others
Based on geography, the global Avanafil market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
VIVUS
Menarini Group
Auxilium Pharmaceuticals
Sanofi
Endo International
JW Pharmaceutical
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL AVANAFIL INDUSTRY
2.1 Summary about Avanafil Industry
2.2 Avanafil Market Trends
2.2.1 Avanafil Production & Consumption Trends
2.2.2 Avanafil Demand Structure Trends
2.3 Avanafil Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 50 mg Avanafil
4.2.2 100 mg Avanafil
4.2.3 200 mg Avanafil
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Hospital
4.3.2 Pharmacy
4.3.3 Online
4.3.4 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 50 mg Avanafil
5.2.2 100 mg Avanafil
5.2.3 200 mg Avanafil
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Hospital
5.3.2 Pharmacy
5.3.3 Online
5.3.4 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 50 mg Avanafil
6.2.2 100 mg Avanafil
6.2.3 200 mg Avanafil
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Hospital
6.3.2 Pharmacy
6.3.3 Online
6.3.4 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 50 mg Avanafil
7.2.2 100 mg Avanafil
7.2.3 200 mg Avanafil
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Hospital
7.3.2 Pharmacy
7.3.3 Online
7.3.4 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 50 mg Avanafil
8.2.2 100 mg Avanafil
8.2.3 200 mg Avanafil
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Hospital
8.3.2 Pharmacy
8.3.3 Online
8.3.4 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 50 mg Avanafil
9.2.2 100 mg Avanafil
9.2.3 200 mg Avanafil
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Hospital
9.3.2 Pharmacy
9.3.3 Online
9.3.4 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 VIVUS
10.1.2 Menarini Group
10.1.3 Auxilium Pharmaceuticals
10.1.4 Sanofi
10.1.5 Endo International
10.1.6 JW Pharmaceutical
10.2 Avanafil Sales Date of Major Players (2017-2020e)
10.2.1 VIVUS
10.2.2 Menarini Group
10.2.3 Auxilium Pharmaceuticals
10.2.4 Sanofi
10.2.5 Endo International
10.2.6 JW Pharmaceutical
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
1.Table Avanafil Product Type Overview
2.Table Avanafil Product Type Market Share List
3.Table Avanafil Product Type of Major Players
4.Table Brief Introduction of VIVUS
5.Table Brief Introduction of Menarini Group
6.Table Brief Introduction of Auxilium Pharmaceuticals
7.Table Brief Introduction of Sanofi
8.Table Brief Introduction of Endo International
9.Table Brief Introduction of JW Pharmaceutical
10.Table Products & Services of VIVUS
11.Table Products & Services of Menarini Group
12.Table Products & Services of Auxilium Pharmaceuticals
13.Table Products & Services of Sanofi
14.Table Products & Services of Endo International
15.Table Products & Services of JW Pharmaceutical
16.Table Market Distribution of Major Players
17.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
18.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
19.Table Global Avanafil Market Forecast (Million USD) by Region 2021f-2026f
20.Table Global Avanafil Market Forecast (Million USD) Share by Region 2021f-2026f
21.Table Global Avanafil Market Forecast (Million USD) by Demand 2021f-2026f
22.Table Global Avanafil Market Forecast (Million USD) Share by Demand 2021f-2026f
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
